Sue O’Leary is no stranger to the challenges of market access.

Having spent the first few years of her career as a UK Hospital Pharmacist, she knows only too well about the need to manage limited resources and optimize new drug use. She has never lost this grounding in the realities of healthcare systems and spent 15 years in the global team at AstraZeneca, as HTAs were an emerging concept and global to local initiatives became a key driver of a successful brand launch.

Sue now heads up the Evidence and Access team at Prime Global, supporting Pharma clients, across the life cycle, to make sure that evidence is optimal not just for launch but beyond. Making sure global dossiers and value stories are underpinned by an understanding of local needs and relatable evidence is key to the development of an optimal GVD.

Education:

• BSc (Hons) Pharmacy
• General Pharmaceutical Registration (GPhC), UK (current)
• Postgraduate Diploma in Health Economics
• Clinical Pharmacy Diploma (London)